Table 2. Logistic regression analyzed the correlation between DLX1 expression and clinicopathologic features of LUAD.
Bold numbers represent significant values.
| Characteristics | Total (N) | Odds Ratio (OR) | P value |
|---|---|---|---|
| T stage (T1 vs. T2 & T3 & T4) | 532 | 1.465 (1.019–2.113) | 0.040 |
| N stage (N0 vs. N1 & N2&N3) | 519 | 1.150 (0.797–1.661) | 0.454 |
| M stage (M0 vs. M1) | 386 | 1.594 (0.705–3.755) | 0.269 |
| Pathologic stage (Stage I vs. Stage II & Stage III & Stage IV) | 527 | 1.487 (1.053–2.103) | 0.025 |
| Gender (Male vs. Female) | 535 | 1.137 (0.809–1.598) | 0.460 |
| Age (>65 vs.≤ 65) | 516 | 1.047 (0.741–1.479) | 0.795 |
| Smoker (Yes vs. No) | 521 | 1.113 (0.682–1.821) | 0.669 |
| Residual tumor (R0 vs. R1 & R2) | 372 | 0.864 (0.318–2.310) | 0.769 |